Monoclonal antibodies against EGFR in non-small cell lung cancerPIRKER, Robert; FILIPITS, Martin.Critical reviews in oncology/hematology. 2011, Vol 80, Num 1, pp 1-9, issn 1040-8428, 9 p.Article

Predictive markers in the adjuvant therapy of non-small cell lung cancerFILIPITS, Martin; PIRKER, Robert.Lung cancer. 2011, Vol 74, Num 3, pp 355-363, issn 0169-5002, 9 p.Article

EGFR-directed monoclonal antibodies in non-small cell lung cancerPIRKER, Robert.Targeted oncology. 2013, Vol 8, Num 1, pp 47-53, issn 1776-2596, 7 p.Article

Targeted Therapies in Lung CancerPIRKER, Robert; FILIPITS, Martin.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 188-206, issn 1381-6128, 19 p.Article

Darbepoetin alfa. A viewpointHEDENUS, Michael; PIRKER, Robert; SMITH, Robert E et al.Drugs (Basel). 2003, Vol 63, Num 11, pp 1075-1077, issn 0012-6667, 3 p.Article

ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ AnalysisBEPLER, Gerold; OLAUSSEN, Ken Andre; FILIPITS, Martin et al.The American journal of pathology. 2011, Vol 178, Num 1, pp 69-78, issn 0002-9440, 10 p.Article

Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancerPOSTMUS, Pieter E; ROCMANS, Pierre; PIRKER, Robert et al.Lung cancer. 2003, Vol 42, pp S3-S6, issn 0169-5002, SUP1Conference Paper

ERCC1 Isoform Expression and DNA Repair in Non―Small-Cell Lung CancerFRIBOULET, Luc; OLAUSSEN, Ken André; FILIPITS, Martin et al.The New England journal of medicine. 2013, Vol 368, Num 12, pp 1101-1110, issn 0028-4793, 10 p.Article

High D-dimer levels are associated with poor prognosis in cancer patientsAY, Cihan; DUNKLER, Daniela; PIRKER, Robert et al.Haematologica (Roma). 2012, Vol 97, Num 8, pp 1158-1164, issn 0390-6078, 7 p.Article

Therapy of small cell lung cancer with emphasis on oral topotecanPIRKER, Robert; BERZINEC, Peter; STANCULEANU, Dana et al.Lung cancer. 2010, Vol 70, Num 1, pp 7-13, issn 0169-5002, 7 p.Article

Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer : International adjuvant lung cancer trial biologic programFILIPITS, Martin; HADDAD, Vincent; POPPER, Helmut H et al.Clinical cancer research. 2007, Vol 13, Num 13, pp 3892-3898, issn 1078-0432, 7 p.Article

Expression of MRP1, LRP and PGP in breast carcinoma patients treated with preoperative chemotherapyRUDAS, Margaretha; FILIPITS, Martin; TAUCHER, Susanne et al.Breast cancer research and treatment. 2003, Vol 81, Num 2, pp 149-157, issn 0167-6806, 9 p.Article

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyGRIDELLI, Cesare; ARDIZZONI, Andrea; DI MAIOF, Massimo et al.Lung cancer. 2010, Vol 68, Num 3, pp 319-331, issn 0169-5002, 13 p.Article

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX) : an open-label randomised phase III trialPIRKER, Robert; PEREIRA, Jose R; ROH, Jae-Kyung et al.Lancet (British edition). 2009, Vol 373, Num 9674, pp 1525-1531, issn 0140-6736, 7 p.Article

Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancerHELLER, Gerwin; GERADTS, Joseph; PIRKER, Robert et al.Breast cancer research and treatment. 2007, Vol 103, Num 3, pp 283-291, issn 0167-6806, 9 p.Article

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapyPOHL, Gudrun; RUDAS, Margaretha; TAUCHER, Susanne et al.Breast cancer research and treatment. 2003, Vol 78, Num 1, pp 97-103, issn 0167-6806, 7 p.Article

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant ChemotherapySHEPHERD, Frances A; DOMERG, Caroline; BOURREDJEM, abderrahmane et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2173-2181, issn 0732-183X, 9 p.Article

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analysesVANSTEENKISTE, Johan; GLASPY, John; HENRY, David et al.Lung cancer. 2012, Vol 76, Num 3, pp 478-485, issn 0169-5002, 8 p.Article

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyOLAUSSEN, Ken A; DUNANT, Ariane; STAHEL, Rolf et al.The New England journal of medicine. 2006, Vol 355, Num 10, pp 983-991, issn 0028-4793, 9 p.Article

High p27^Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage Breast cancer receiving adjuvant treatment with tamoxifen plus goserelinPOHL, Gudrun; RUDAS, Margaretha; JAKESZ, Raimund et al.Journal of clinical oncology. 2003, Vol 21, Num 19, pp 3594-3600, issn 0732-183X, 7 p.Article

P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patientsZÖCHBAUER-MÜLLER, Sabine; FILIPITS, Martin; RUDAS, Margaretha et al.Anticancer research. 2001, Vol 21, Num 1A, pp 119-124, issn 0250-7005Article

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancerPUJOL, Jean-Louis; PIRKER, Robert; VON HEYDEBRECK, Anja et al.Lung cancer. 2014, Vol 83, Num 2, pp 211-218, issn 0169-5002, 8 p.Article

PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outsOLAUSSEN, Ken A; ADAM, Julien; KAYITALIRE, Louis et al.Lung cancer. 2013, Vol 80, Num 2, pp 216-222, issn 0169-5002, 7 p.Article

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studiesLICITRA, Lisa; STÖRKEL, Stephan; CIARDIELLO, Fortunato et al.European journal of cancer (1990). 2013, Vol 49, Num 6, pp 1161-1168, issn 0959-8049, 8 p.Article

The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLCGATELY, Kathy; O'FLAHERTY, John; CAPPUZZO, Frederico et al.Journal of clinical pathology. 2012, Vol 65, Num 1, pp 1-7, issn 0021-9746, 7 p.Article